Memorial Sloan Kettering Cancer Center

New York, New York, United States mskcc.org

Overview

Memorial Sloan Kettering Cancer Center is one of the world's premier cancer treatment and research institutions. With cutting-edge research and a comprehensive care program, it offers extensive treatments for various cancer types while advancing oncology science.

Therapeutic areas

OncologyHematology

API / Drug Master Files

Memorial Sloan Kettering Cancer Center holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • [I124] FIAUInactive2001-06-29
  • SODIUM IODIDE-124Inactive2001-01-03

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Memorial Sloan Kettering Cancer Center in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Acceleron Pharma Inc.
United States
Acerta Pharma LLC
USA
Acrotech Biopharma, Inc.
United States
Allogene Therapeutics, Inc.
United States
Apollomics Inc.
United States
Array BioPharma Inc.
United States
Athenex, Inc.
United States
Baxalta Incorporated
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo